Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: Synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities

Dyson, 2006, Metal-based antitumor drugs in the post genomic era, Dalton Trans., 1929, 10.1039/b601840h Ang, 2006, Classical and non-classical ruthenium-based anticancer drugs: toward targeted chemotherapy, Eur. J. Inorg. Chem., 20, 4003, 10.1002/ejic.200600723 Guo, 1999, Metals in medicine, Angew. Chem. Int. Ed., 38, 1512, 10.1002/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y Guo, 1999, Medicinal inorganic chemistry, Adv. Inorg. Chem., 49, 183, 10.1016/S0898-8838(08)60271-8 Arion, 2003, Synthesis, X-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole)Ru(III) complexes, Inorg. Chem., 42, 6024, 10.1021/ic034605i Pineto, 1996 Clarke, 2002, Ruthenium metallopharmaceuticals, Coord. Chem. Rev., 232, 69, 10.1016/S0010-8545(02)00025-5 Ager, 2006, Phosphoramidite-controlled asymmetric hydrogenation with rhodium catalysts, Platinum Met. Rev., 50, 54, 10.1595/147106706X111582 Levina, 2009, Recent developments in ruthenium anticancer drugs, Metallomics, 1, 458, 10.1039/b904071d Bruijnincx, 2008, New trends for metal complexes with anticancer activity, Curr. Opin. Chem. Biol., 12, 197, 10.1016/j.cbpa.2007.11.013 Che, 2002, Ruthenium and osmium porphyrin carbene complexes: synthesis, structure, and connection to the metal-mediated cyclopropanation of alkenes, Coord. Chem. Rev., 231, 151, 10.1016/S0010-8545(02)00117-0 Erkkila, 1999, Recognition and reaction of metallointercalators with DNA, Chem. Rev., 99, 2777, 10.1021/cr9804341 Mansouri-Torshizi, 2008, 2,2′-Bipyridinebutyldithiocarbamatoplatinum(II) and palladium(II) complexes: synthesis, characterization, cytotoxicity and rich DNA-binding studies, Bioorg. Med. Chem., 16, 9616, 10.1016/j.bmc.2008.08.021 Barton, 1986, Metals and DNA: molecular left-handed complements, Science, 233, 727, 10.1126/science.3016894 Francois, 1988, Periodic cleavage of poly (dA) by oligothymidylates covalently linked to the 1,10-phenanthroline-copper complex, Biochemistry, 27, 2272, 10.1021/bi00407a004 Guo, 1990, Drug binding by branched DNA molecules: analysis by chemical footprinting of intercalation into an immobile junction, Biochemistry, 29, 570, 10.1021/bi00454a034 Karlin, 2011, vol. 57 Palchaudhuri, 2007, DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action, Curr. Opin. Biotechnol., 18, 497, 10.1016/j.copbio.2007.09.006 Zhang, 2005, Synthesis, crystal structure, cytotoxic activity and DNA-binding properties of the copper (II) and zinc (II) complexes with 1-[3-(2-pyridyl)pyrazol-1-ylmethyl]naphthalene, J. Inorg. Biochem., 99, 1119, 10.1016/j.jinorgbio.2005.02.005 Asadi, 2004, Thermodynamic and spectroscopic study on the binding of cationic Zn(II) and Co(II) tetrapyridinoporphyrazines to calf thymus DNA: the role of the central metal in binding parameters, New J. Chem., 28, 1227, 10.1039/b404068f Raman, 2011, Studies on DNA binding, electrochemical activation, DNA photocleavage, and biopotency of N and O donor bidentate ligands with Cu(II), Co(II), and Zn(II), J. Coord. Chem., 64, 534, 10.1080/00958972.2010.551767 Tang, 2006, Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR, and molecular modeling, Bioorg. Med. Chem., 14, 3210, 10.1016/j.bmc.2005.12.034 Zhou, 2008, Characterization of the interaction between furosemide and bovine serum albumin, J. Mol. Struct., 872, 190, 10.1016/j.molstruc.2007.02.035 Ghosh, 2009, A spectroscopic investigation into the interactions of 3′-O-carboxy esters of thymidine with bovine serum albumin, Biopolymers, 91, 737, 10.1002/bip.21220 Beckman, 1998, The free radical theory of ageing, Phys. Rev., 78, 447 Halliwel, 1989 Jiang, 2013, Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes, J. Photochem. Photobiol., B, 129, 48, 10.1016/j.jphotobiol.2013.09.009 Liu, 2010, Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity, Eur. J. Med. Chem., 45, 3087, 10.1016/j.ejmech.2010.03.042 Wang, 2012, Cytotoxicity, cell cycle arrest, antioxidant activity and interaction of dibenzoxanthenes derivatives with DNA, DNA Cell Biol., 31, 1468, 10.1089/dna.2012.1726 Krstic, 2010, New ruthenium(II) complexes with N-alkylphenothiazines: synthesis, structure, in vivo activity as free radical scavengers and in vitro cytotoxicity, Eur. J. Med. Chem., 45, 3669, 10.1016/j.ejmech.2010.05.013 Kang, 1997, Synthesis and characterization of aluminum and gallium complexes of heterocyclic carboxaldehyde thiosemicarbazones. Single-crystal structure of [(MeAl){NC4H3CHNNC(S)NiC3H7}(AlMe2)]2 and (GaMe2)2[SC4H3CHNNC(S)NPh], Organometallics, 16, 5522, 10.1021/om970660l West, 1999, Spectral and structural studies of iron(III), cobalt(II, III) and nickel(II) complexes of 2-pyridineformamide-N(4)-methylthiosemicarbazone, Polyhedron, 18, 2919, 10.1016/S0277-5387(99)00210-7 Tarasconi, 2000, Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones, Bioorg. Med. Chem., 8, 157, 10.1016/S0968-0896(99)00260-6 Kumar, 1993, Cobalt(II) complexes OP some semicarbazones and thiosemicarbazones, Synth. React. Inorg. Met.-Org. Chem., 23, 671, 10.1080/15533179308016665 Ackerman, 1999, Structural and spectral studies of copper(II) and nickel(II) complexes of pyruvaldehyde mixed bis{N(4)-substituted thiosemicarbazones}, Polyhedron, 18, 2759, 10.1016/S0277-5387(99)00173-4 Teoh, 1999, Synthesis, crystal structure and biological activity of thiophene-2-carboxaldehyde thiosemicarbazone and its tin complexes, J. Organomet. Chem., 580, 17, 10.1016/S0022-328X(98)01099-7 Bermejo, 1999, Synthesis, characterization and antifungal activity of group 12 metal complexes of 2-acetylpyridine-4N-ethylthiosemicarbazone (H4EL) and 2-acetylpyridine-N-oxide-4N-ethylthiosemicarbazone (H4ELO), Polyhedron, 18, 3695, 10.1016/S0277-5387(99)00309-5 Abram, 1998, Polyhedron, 17, 131, 10.1016/S0277-5387(97)00240-4 Papathanasis, 2004, Palladium(II) and platinum(II) complexes of 2-hydroxy acetophenone N(4)-ethylthiosemicarbazone – crystal structure and description of bonding properties, Inorg. Chim. Acta, 357, 4113, 10.1016/j.ica.2004.06.048 Kovala-Demertzi, 2004, First use of a palladium complex with a thiosemicarbazone ligand as catalyst precursor for the Heck reaction, Tetrahedron Lett., 45, 2923, 10.1016/j.tetlet.2004.02.062 Casas, 1993, (p-Anisaldehyde thiosemicarbazonato) dimethylthallium(III): an unusual structure for a co-ordinated thiosemicarbazone, J. Chem. Soc. Dalton Trans., 2, 353, 10.1039/DT9930000353 Kostas, 2006, Microwave-promoted Suzuki–Miyaura cross-coupling of aryl halides with phenylboronic acid under aerobic conditions catalyzed by a new palladium complex with a thiosemicarbazone ligand, Tetrahedron Lett., 47, 4403, 10.1016/j.tetlet.2006.04.088 Vogel, 1989 Sathiya kamatchi, 2012, Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro, Dalton Trans., 41, 2066, 10.1039/C1DT11273B Poddar, 1974, Some ruthenium(III) complexes with triphenylarsine, J. Inorg. Nucl. Chem. Lett., 10, 221, 10.1016/0020-1650(74)80199-6 Natarajan, 1997, Mixed complexes of ruthenium(III) and ruthenium(II) with triphenylphosphine or triphenylarsine and other ligands, J. Inorg. Nucl. Chem., 39, 431, 10.1016/0022-1902(77)80056-0 Markovic, 2010, Theoretical study on structural and mechanistic aspects of synthesis of a 3-aminopyrazole derivative, Tetrahedron, 66, 6205, 10.1016/j.tet.2010.05.093 Blois, 1958, Antioxidant determination by the use of stable free radicals, Nature, 29, 1199, 10.1038/1811199a0 Nash, 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction, Biochem. J., 55, 416, 10.1042/bj0550416 Green, 1982, Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids, Anal. Biochem., 126, 131, 10.1016/0003-2697(82)90118-X Ruch, 1989, Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea, Carcinogenesis, 10, 1003, 10.1093/carcin/10.6.1003 Sambrook, 1989 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Monks, 1991, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst., 83, 757, 10.1093/jnci/83.11.757 Pal, 2002, Ruthenium(II) complexes containing RuN4O2 spheres assembled via pyridine-imine-amide coordination. Syntheses, structures, properties and protonation behavior of coordinated amide, J. Chem. Soc., Dalton Trans., 2102, 10.1039/b110912j Lever, 1989 Nakajima, 2001, Thermal and photo substitution reactivity and crystal structures of tridentate Schiff base–ruthenium(II) complexes containing phosphorus or sulfur donor atoms, Inorg. Chim. Acta, 325, 36, 10.1016/S0020-1693(01)00628-4 Chattopadhyay, 1989, A study of ruthenium complexes of some selected N—S donors Part II. Ligational behavior of 2-formylpyridine(4-phenyl) thiosemicarbazone toward ruthenium, Inorg. Chim. Acta, 163, 245, 10.1016/S0020-1693(00)83458-1 Khan, 1991, Ruthenium(III) Schiff base chloro and carbonyl complexes: synthesis, characterization and EPR studies, Polyhedron, 10, 2559, 10.1016/S0277-5387(00)81330-3 Samanta, 2001, Mononuclear and dinuclear ruthenium(II)/(III) salicylates incorporating azoimine functionalities as ancillary ligands. Synthesis, spectroscopic and electron-transfer properties, J. Chem. Soc., Dalton Trans., 1827, 10.1039/b100163i Venkatachalam, 2005, Synthesis, spectra, redox property and catalytic activity of ruthenium(III) Schiff base complexes, Indian J. Chem. A, 44A, 705 Khan, 1990, Synthesis, characterization, and EPR studies of stable ruthenium(III) Schiff base chloro and carbonyl complexes, Inorg. Chem., 29, 2320, 10.1021/ic00337a026 Medhi, 1980, Electron spin resonance studies of some ruthenium(III) complexes, Inorg. Chem., 19, 1381, 10.1021/ic50207a055 Chakraborty, 2000, Ruthenium(II)/(III) bipyridine heterochelates incorporating phenolato imine functionalities. Synthesis, crystal structure, spectroscopic and electron-transfer properties and solution reactivities, J. Chem. Soc., Dalton Trans., 2875, 10.1039/b001663m Thangadurai, 2002, Synthesis and characterization of ruthenium(III) complexes containing monobasic bidentate Schiff bases and their biological activities, Synth. React. Inorg. Met.-Org. Chem., 32, 329, 10.1081/SIM-120003211 Basu, 1988, Synthesis and spectral and electrochemical properties of di-2-pyridyl ketone complexes of ruthenium and their reactions, Inorg. Chem., 27, 4539, 10.1021/ic00298a008 Barton, 1984, Photoactivated stereospecific cleavage of double-helical DNA by cobalt(III) complexes, J. Am. Chem. Soc., 106, 2466, 10.1021/ja00320a058 Bast, 1991, Oxidants and antioxidants: state of the art, Am. J. Med., 91, 2, 10.1016/0002-9343(91)90278-6 Tsai, 2001, Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise, Free Radical Biol. Med., 31, 1465, 10.1016/S0891-5849(01)00729-8 Halliwell, 1991, Reactive oxygen species in living systems: source, biochemistry and role in human disease, Am. J. Med., 91, 14S, 10.1016/0002-9343(91)90279-7 Gutteridge, 1994, Biological origin of free radicals, and mechanisms of antioxidant protection, Chem. Biol. Interact., 91, 133, 10.1016/0009-2797(94)90033-7 Udilova, 2003, The antioxidant activity of caroverine, Biochem. Pharmacol., 65, 59, 10.1016/S0006-2952(02)01452-1 Sathiya Kamatchi, 2012, Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand, impact of oxidation state and co-ligands on anticancer activity in vitro, Dalton Trans., 41, 2066, 10.1039/C1DT11273B Satyanarayana, 1992, Neither. DELTA.- nor. LAMBDA.- tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation, Biochemistry, 31, 9319, 10.1021/bi00154a001 Yu, 2013, Ruthenium(II) polypyridyl complexes as G-quadruplex inducing and stabilizing ligands in telomeric DNA, Metallomics, 5, 222, 10.1039/c3mt20214c Shahabadi, 2013, DNA interaction studies of a novel Cu(II) complex as an intercalator containing curcumin and bathophenanthroline ligands, J. Photochem. Photobiol., B, 122, 45, 10.1016/j.jphotobiol.2013.03.002 Raja, 2011, Effect of terminal N-substitution in 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the mode of coordination, structure, interaction with protein, radical scavenging and cytotoxic activity of copper(II) complexes, Dalton Trans., 40, 4548, 10.1039/c0dt01657h Raja, 2011, Biological evaluation of a novel water soluble sulfur bridged binuclear copper(II) thiosemicarbazone complex, Eur. J. Med. Chem., 46, 4584, 10.1016/j.ejmech.2011.07.038 Friedman, 1990, A molecular light switch for DNA: Ru(bpy)2(dppz)2+, J. Am. Chem. Soc., 112, 4960, 10.1021/ja00168a052 Clarke, 1980, Reduction and subsequent binding of ruthenium ions catalyzed by subcellular components, J. Inorg. Biochem., 12, 79, 10.1016/S0162-0134(00)80045-8 Clarke, 2003, Ruthenium metallopharmaceuticals, Coord. Chem. Rev., 236, 209, 10.1016/S0010-8545(02)00312-0